Indefinite Delivery Contract 36E79725D0018

Award Date 6/3/25
Last Date to Order 6/2/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for the delivery of Topiramate tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, unrestricted contract was issued by the VA National Acquisition Center, with a total ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025. The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical...
This federal contract IDV award to Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company based in Florida, is a single-award Indefinite Delivery Contract (IDC) valued at up to $28,235,184.10. The contract was awarded by the Defense Logistics Agency, a defense agency, with no set-aside designations, allowing Exelan to compete openly. The contract encompasses the delivery of a wide range of generic pharmaceutical products to federal healthcare agencies such as the Department of...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The single-award contract, which has a ceiling value of $16,283,304.30, is for the supply of Cyclobenzaprine HCL 10mg tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a base year with four one-year option periods, effective May 15,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
The Department of Veterans Affairs (VA) National Acquisition Center awarded Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, a single-award Indefinite Delivery Contract (IDC) for the supply of pharmaceutical products, including ibuprofen, under the agency's Pharmaceutical Repackaging Program. The contract has a ceiling value of $15,582,998.52 and a period of performance from June 20, 2022 to June 19, 2025. Under this IDC, the VA has issued multiple firm...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract, awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., provides for the delivery of Zonisamide capsules in various dosages to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, firm fixed-price contract has a period of performance from June 15, 2021 to June 14, 2022, with four one-year option periods, for a total ceiling value of $8,974,952.04....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...

The federal contract IDV award is for the delivery of Cyclobenzaprine HCL Tablets to multiple federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The single-award, unrestricted contract was issued by the VA National Acquisition Center and has a base period of one year with four one-year option periods, for a total potential period of performance through June 2, 2036. The ceiling value of the contract is $7,656,786.70.

The contract aims to ensure a consistent and reliable supply of Cyclobenzaprine HCL Tablets in various package sizes, ranging from 30 to 1,000 tablets per bottle. The estimated annual usage varies by package size, with the highest demand for the 90-count bottles at 252,863 bottles per year. The contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida, that specializes in manufacturing, distributing, and repackaging pharmaceutical products for federal healthcare agencies. Exelan has been awarded this contract as a prime contractor without the use of any subcontractors, and the contract will be distributed through the VA's and DoD's Pharmaceutical Prime Vendor Programs.

Generated 4/4/25, 9:44 AM